Form 4: Sera Prognostics Chief Scientific Officer Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing


John J. Boniface, Chief Scientific Officer of Sera Prognostics, sold 4,902 shares of Class A Common Stock to cover tax withholding obligations related to vesting restricted stock units.

Summary

  • On May 8, 2024, John J. Boniface, the Chief Scientific Officer of Sera Prognostics, sold 4,902 shares of Class A Common Stock.
  • The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs).
  • The shares were sold at a weighted average price of $9.59, with individual transactions ranging from $9.14 to $10.55.
  • Following the transaction, Boniface directly owns 134,869 shares of Sera Prognostics.
  • The sale was mandated by the issuer's policy to cover tax obligations through 'sell to cover' transactions.

Sentiment

Score: 5

Explanation: Neutral sentiment as the transaction is a routine sale of shares to cover tax obligations and doesn't necessarily reflect a change in the insider's confidence in the company.

Industry Context

This is a routine Form 4 filing, indicating a transaction by a company insider. Such filings are common and provide transparency into the trading activities of company executives and directors. The sale appears to be related to tax obligations, which is a typical reason for insider sales.

Stakeholder Impact

  • The sale of shares by an officer could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates

DateDescription
05/08/2024Date of the stock sale transaction.
05/10/2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.